BAC Slides Further as Peers Find Their Footing

Bank of America has dropped another leg lower this week, closing at $50.01 on Friday, extending a slide that has now taken the stock down 9% over the past month while most of its large-bank peers have stabilised or recovered.

The peer divergence has deepened since last week's note. On the week, JPMorgan gained 1.6%, Wells Fargo added 1.2%, and Fifth Third rose 1.7%. BAC fell 1.1% over the same period. Friday alone saw a 2.2% decline, while Citizens Financial dropped 3.0% and US Bancorp fell 2.0%, suggesting broader sector pressure returned to close the week. But the month-long picture remains distinctly BAC-specific: the stock is now trading at $50.01, versus a Street consensus target of $62.84, a gap of nearly 26%. That distance has opened not because analysts have turned bearish, but because the stock has moved faster to the downside than targets have been adjusted.

The borrow market offers no drama. Availability is effectively unlimited, borrow costs have fallen sharply, now at 0.16% after dropping more than 37% on the week and 64% over the past month. Short interest is just 1.2% of the free float, and has edged up only modestly, around 6.8% over 30 days in absolute share terms. The ORTEX short score sits at 30, firmly in the lower half of the range. None of this points to a short-driven selloff. As was the case last week, the pressure is coming from somewhere else entirely.

The analyst community has trimmed targets without abandoning their bullish posture. Following the Q3 earnings print on October 14, which sent the stock down 4.2% on the day and 5.9% over the following five days, virtually every major bank analyst cut their price target. Morgan Stanley's Betsy Graseck reduced hers from $67 to $61 while holding Overweight. Barclays moved from $72 to $68, also keeping Overweight. Wells Fargo, Citigroup, RBC Capital and Keefe Bruyette all made similar moves: lower targets, unchanged positive ratings. The sole exception was Baird, which upgraded from Neutral to Outperform on the day of results, keeping its $62 target in place. The net effect is a consensus that still has the stock trading at a 26% discount to fair value, but which has already absorbed the bad news from the quarter. Options positioning is consistent with this: the put/call ratio is at 1.17, almost exactly in line with its 20-day average of 1.17, and well below the 52-week high of 1.67. There is no particular rush for downside protection at current prices.

What the Q3 print delivered was a set of facts that matter for a capital-intensive bank. The CET1 ratio fell to 11.2% and the supplementary leverage ratio dropped 20 basis points to 5.5%. Those numbers sit against a backdrop where the bull case, 7.2% revenue growth to $30.3 billion, 9% growth in net interest income, and 21% growth in consumer banking net income to $3.1 billion, is genuinely strong. Loan growth has been unbroken for nine consecutive quarters, according to FDIC call report data. Total deposits hit a record for any Q2 in the dataset's history at $2.13 trillion. Buyback spend of $6.0 billion in Q2 was the largest in six years and ran 13% above the prior year's equivalent quarter. The tension is real: the operating business is growing, capital ratios are slipping, and the stock is getting valued accordingly.

The underlying alt data adds texture without changing the story. None of the datasets tracked for BAC, including FDIC call reports, SEC ABS trustee filings, and CFPB complaint data, carry a measured lead against the company's reported financials, so they inform context rather than direction. Retail attention, as proxied by Wikipedia views, is running 1.3 standard deviations above its own 90-day average, a signal of elevated interest rather than anything more. The next earnings print is scheduled for January 15, 2027, giving the market 76 days to decide whether the capital ratio trajectory or the revenue momentum is the better anchor for the stock.

What to watch next is whether the spread between BAC's performance and its peer group closes, and in which direction: either peers rotate back into the same regulatory and capital headwinds that have weighed on BAC, or BAC finds a catalyst that brings it back in line with a sector that has otherwise held up well through October.